These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22887003)

  • 1. Dynamic contrast-enhanced MR perfusion imaging of head and neck tumors at 3 Tesla.
    Furukawa M; Parvathaneni U; Maravilla K; Richards TL; Anzai Y
    Head Neck; 2013 Jul; 35(7):923-9. PubMed ID: 22887003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic efficacy of dynamic contrast-enhanced magnetic resonance perfusion imaging in detecting local tumor recurrence in patients with head and neck malignancies after definitive treatment.
    Lathika AG; Jayasankaran SC; Chelakkot PG; Thankappan K; Moorthy S
    J Cancer Res Ther; 2024 Apr; 20(3):793-801. PubMed ID: 39023585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of soft tissue lesions affecting the masticator space with dynamic contrast enhanced MRI].
    Tang WQ; Le WJ; Wang PZ; Shi HM; Yu Q
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):711-5. PubMed ID: 24495719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
    Yuan Y; Kuai XP; Chen XS; Tao XF
    Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DCE and DSC MR perfusion imaging in the differentiation of recurrent tumour from treatment-related changes in patients with glioma.
    Shin KE; Ahn KJ; Choi HS; Jung SL; Kim BS; Jeon SS; Hong YG
    Clin Radiol; 2014 Jun; 69(6):e264-72. PubMed ID: 24594379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors].
    Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Recurrent Head and Neck Cancer From Postradiation Changes.
    Abdel Razek AA; Gaballa G; Ashamalla G; Alashry MS; Nada N
    J Comput Assist Tomogr; 2015; 39(6):849-54. PubMed ID: 26359584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesions.
    Schaefer JF; Vollmar J; Schick F; Vonthein R; Seemann MD; Aebert H; Dierkesmann R; Friedel G; Claussen CD
    Radiology; 2004 Aug; 232(2):544-53. PubMed ID: 15215548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
    Bisdas S; Baghi M; Wagenblast J; Vogl TJ; Thng CH; Koh TS
    J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging.
    Engelbrecht MR; Huisman HJ; Laheij RJ; Jager GJ; van Leenders GJ; Hulsbergen-Van De Kaa CA; de la Rosette JJ; Blickman JG; Barentsz JO
    Radiology; 2003 Oct; 229(1):248-54. PubMed ID: 12944607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic susceptibility contrast perfusion MR imaging in distinguishing malignant from benign head and neck tumors: a pilot study.
    Razek AA; Elsorogy LG; Soliman NY; Nada N
    Eur J Radiol; 2011 Jan; 77(1):73-9. PubMed ID: 19695805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of head and neck tumors: comparison of T1-weighted contrast-enhanced fat-suppressed images with conventional T2-weighted and fast spin-echo T2-weighted images.
    Ross MR; Schomer DF; Chappell P; Enzmann DR
    AJR Am J Roentgenol; 1994 Jul; 163(1):173-8. PubMed ID: 8010208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conspicuity of tumors of the head and neck on fat-suppressed MR images: T2-weighted fast-spin-echo versus contrast-enhanced T1-weighted conventional spin-echo sequences.
    Dubin MD; Teresi LM; Bradley WG; Jordan JE; Pema PJ; Goergen SK; Tam JK
    AJR Am J Roentgenol; 1995 May; 164(5):1213-21. PubMed ID: 7717234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of spatiotemporal changes for the classification of dynamic contrast-enhanced magnetic-resonance breast lesions.
    Milenković J; Hertl K; Košir A; Zibert J; Tasič JF
    Artif Intell Med; 2013 Jun; 58(2):101-14. PubMed ID: 23548472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?
    Yabuuchi H; Matsuo Y; Kamitani T; Setoguchi T; Okafuji T; Soeda H; Sakai S; Hatakenaka M; Nakashima T; Oda Y; Honda H
    Radiology; 2008 Dec; 249(3):909-16. PubMed ID: 18941162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy.
    van Rijswijk CS; Geirnaerdt MJ; Hogendoorn PC; Taminiau AH; van Coevorden F; Zwinderman AH; Pope TL; Bloem JL
    Radiology; 2004 Nov; 233(2):493-502. PubMed ID: 15459325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.